Pharmacy Practice NewsAs Medicare’s GLP-1 Bridge Program Launches, ISMP Offers Guidance for Pharmacists

🎓 Expert Commentary / Peer Perspective

Lower-cost GLP-1 access may bring more first-time users into community and ambulatory pharmacy settings. ISMP is encouraging pharmacists to treat each dispensing encounter as a medication-safety and adherence intervention opportunity.

Professional Impact

• Monthly GLP-1 dose titration creates recurring risk for dispensing incorrect strengths, outdated prescriptions, and administration confusion.
• Older adults initiating therapy may require additional support around adverse effects, hydration, injection technique, and polypharmacy.
• Growing demand may increase exposure to compounded, counterfeit, or unregulated GLP-1 products obtained outside traditional channels.
• Medication-error reporting can identify recurring safety vulnerabilities involving dosing, dispensing, labeling, and administration practices.

Action Items

• Review dose progression and titration schedules at every GLP-1 dispense.
• Verify product strength, device type, and patient understanding before dispensing.
• Monitor for adherence barriers, adverse effects, and administration errors.
• Educate patients about legitimate product sourcing and medication-safety concerns.
• Report medication errors, near misses, and hazardous conditions through established safety programs.